A carregar...
Emerging serine-threonine kinase inhibitors for treating ovarian cancer
INTRODUCTION: Ovarian cancer is the leading cause of gynecologic cancer death, owing to high rates of incurable, recurrent disease after initial treatment. Serine threonine kinases (STKs) have been proposed as potential therapeutic targets in ovarian cancer because of their role in the initiation an...
Na minha lista:
| Publicado no: | Expert Opin Emerg Drugs |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7526049/ https://ncbi.nlm.nih.gov/pubmed/31755325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2019.1696773 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|